Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02957 | 34184611 | Ann Med | Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016. | 2021 | Details |
| A02984 | 34174048 | J Gastrointestin Liver Dis | Non-alcoholic fatty liver disease and cardiovascular disease: a close relationship. | 2021 | Details |
| A02989 | 34172319 | Nutr Metab Cardiovasc Dis | Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism. | 2021 | Details |
| A02996 | 34171051 | Rom J Morphol Embryol | Pediatric nonalcoholic fatty liver disease - a changing diagnostic paradigm. | 2021 | Details |
| A03005 | 34168043 | BMJ Open Gastroenterol | Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A03042 | 34155792 | Liver Int | Natural history of NASH. | 2021 | Details |
| A03047 | 34154037 | J Gastroenterol Hepatol | Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. | 2021 | Details |
| A03056 | 34152053 | J Sleep Res | Metabolic dysfunction in OSA: Is there something new under the sun? | 2021 | Details |
| A03061 | 34147478 | Eur J Pharmacol | Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease. | 2021 | Details |
| A03065 | 34146602 | Diabetes Res Clin Pract | Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study. | 2021 | Details |
| A03073 | 34141981 | Hepatol Commun | Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study. | 2021 | Details |
| A03087 | 34136174 | Food Sci Nutr | Synergistic effects of black ginseng and aged garlic extracts for the amelioration of nonalcoholic fatty liver disease (NAFLD) in mice. | 2021 | Details |
| A03098 | 34132110 | Am J Physiol Gastrointest Liver Physiol | Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk. | 2021 | Details |
| A03105 | 34129272 | Hepatol Res | MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach. | 2021 | Details |
| A03116 | 34124059 | Front Cell Dev Biol | Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. | 2021 | Details |
| A03135 | 34118091 | J Intern Med | Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease. | 2021 | Details |
| A03172 | 34103552 | Sci Rep | Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. | 2021 | Details |
| A03182 | 34097928 | Prog Lipid Res | Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. | 2021 | Details |
| A03184 | 34096467 | Bioengineered | The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. | 2021 | Details |
| A03202 | 34091530 | Chin Med J (Engl) | Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016. | 2021 | Details |
| A03222 | 34082054 | Diabetes Res Clin Pract | Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study. | 2021 | Details |
| A03226 | 34081289 | Hepatol Int | Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease. | 2021 | Details |
| A03242 | 34074100 | Vnitr Lek | Rheumatoid arthritis and metabolic disorders. | 2021 | Details |
| A03243 | 34074098 | Vnitr Lek | Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease. | 2021 | Details |
| A03250 | 34072137 | Nutrients | Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials. | 2021 | Details |
| A03258 | 34068776 | Diagnostics (Basel) | Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03259 | 34068699 | J Clin Med | Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate? | 2021 | Details |
| A03289 | 34059612 | Curr Opin Cardiol | Update on cardiovascular risk in nonalcoholic fatty liver disease. | 2021 | Details |
| A03303 | 34051282 | Diabetes Res Clin Pract | Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease. | 2021 | Details |
| A03312 | 34049388 | J Nutr | Consumption of Preserved Egg Is Associated with Modestly Increased Risk of Nonalcoholic Fatty Liver Disease in Chinese Adults. | 2021 | Details |
| A03327 | 34043417 | Circ Res | Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia. | 2021 | Details |
| A03332 | 34040583 | Front Endocrinol (Lausanne) | Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03344 | 34033923 | Clin Gastroenterol Hepatol | Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD. | 2021 | Details |
| A03352 | 34031802 | Dig Dis Sci | Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study). | 2021 | Details |
| A03372 | 34027109 | Clin Exp Hepatol | Non-alcoholic fatty liver disease and lipotoxicity. | 2021 | Details |
| A03377 | 34025131 | J Ginseng Res | Effect of Korean Red Ginseng on metabolic syndrome. | 2020 | Details |
| A03381 | 34023517 | Spine J | Cardiovascular and metabolic morbidity following spinal cord injury. | 2021 | Details |
| A03399 | 34016462 | Transplant Proc | Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study. | 2021 | Details |
| A03410 | 34011624 | BMJ Open Gastroenterol | Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy. | 2021 | Details |
| A03412 | 34011282 | BMC Cardiovasc Disord | Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis. | 2021 | Details |
| A03415 | 34007802 | J Clin Transl Hepatol | Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population. | 2021 | Details |
| A03450 | 33995404 | Front Immunol | Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance. | 2021 | Details |
| A03452 | 33994867 | Int J Biol Sci | MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03465 | 33992031 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms. | 2021 | Details |
| A03472 | 33991395 | Chem Biodivers | The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review. | 2021 | Details |
| A03475 | 33990287 | J Med Vasc | Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03500 | 33982065 | J Clin Endocrinol Metab | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality. | 2021 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03541 | 33962617 | Health Qual Life Outcomes | Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey. | 2021 | Details |
| A03545 | 33961787 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. | 2021 | Details |
| A03552 | 33960110 | Obes Rev | Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat-A systematic review and meta-analysis. | 2021 | Details |
| A03581 | 33946154 | Microorganisms | High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. | 2021 | Details |
| A03593 | 33939118 | Drugs | Targeting AMPK by Statins: A Potential Therapeutic Approach. | 2021 | Details |
| A03598 | 33937292 | Front Med (Lausanne) | Test-Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients. | 2021 | Details |
| A03607 | 33933056 | BMC Endocr Disord | Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis. | 2021 | Details |
| A03637 | 33923295 | Int J Mol Sci | Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. | 2021 | Details |
| A03638 | 33923255 | Nutrients | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. | 2021 | Details |
| A03639 | 33923175 | Cells | Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity. | 2021 | Details |
| A03646 | 33921359 | Diagnostics (Basel) | Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. | 2021 | Details |
| A03652 | 33919190 | Antioxidants (Basel) | The Impact of H2S on Obesity-Associated Metabolic Disturbances. | 2021 | Details |
| A03655 | 33918456 | Int J Mol Sci | Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response. | 2021 | Details |
| A03657 | 33917919 | Cancers (Basel) | The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. | 2021 | Details |
| A03659 | 33917867 | J Clin Med | Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective. | 2021 | Details |
| A03668 | 33913734 | J Altern Complement Med | Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study. | 2021 | Details |
| A03673 | 33911167 | Sci Rep | Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03711 | 33895191 | Pharmacol Ther | The pathophysiological function of non-gastrointestinal farnesoid X receptor. | 2021 | Details |
| A03716 | 33894145 | Lancet | Non-alcoholic fatty liver disease. | 2021 | Details |
| A03733 | 33885048 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study. | 2021 | Details |
| A03740 | 33882758 | Expert Rev Clin Pharmacol | Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. | 2021 | Details |
| A03748 | 33879084 | BMC Gastroenterol | Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol. | 2021 | Details |
| A03767 | 33871081 | J Gastroenterol Hepatol | Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population. | 2021 | Details |
| A03780 | 33866274 | J Stroke Cerebrovasc Dis | Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study. | 2021 | Details |
| A03785 | 33864798 | Metabolism | Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. | 2021 | Details |
| A03797 | 33861444 | Adv Exp Med Biol | Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review. | 2021 | Details |
| A03798 | 33861434 | Adv Exp Med Biol | The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 | Details |
| A03804 | 33860188 | ACS Pharmacol Transl Sci | Pyruvate Dehydrogenase as a Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03814 | 33859484 | Diabetes Metab Syndr Obes | Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03830 | 33855376 | Minerva Surg | NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. | 2021 | Details |
| A03845 | 33849361 | Expert Opin Drug Discov | The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. | 2021 | Details |
| A03851 | 33847141 | J Am Heart Assoc | Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03856 | 33844769 | Rev Med Chil | [The impact on metabolic and reproductive diseases of low-carbohydrate and ketogenic diets]. | 2020 | Details |
| A03874 | 33837670 | Liver Transpl | Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications. | 2021 | Details |
| A03876 | 33836983 | J Clin Lipidol | Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. | 2021 | Details |
| A03884 | 33833450 | Nat Rev Cardiol | Global epidemiology of dyslipidaemias. | 2021 | Details |
| A03886 | 33833347 | Sci Rep | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. | 2021 | Details |
| A03887 | 33832846 | Z Med Phys | Towards detection of inflammation in adipose tissue: Microscopic field simulations to estimate water signal properties. | 2021 | Details |
| A03888 | 33832643 | Maturitas | Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations. | 2021 | Details |
| A03907 | 33823622 | Angiology | Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03910 | 33822497 | Int J Med Mushrooms | Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review). | 2021 | Details |
| A03913 | 33821832 | Clin Transl Gastroenterol | Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study. | 2021 | Details |
| A03919 | 33817364 | Heliyon | Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease. | 2021 | Details |
| A03928 | 33815296 | Front Endocrinol (Lausanne) | Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors. | 2021 | Details |
| A03948 | 33810315 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level. | 2021 | Details |
| A03957 | 33808036 | Biomolecules | Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. | 2021 | Details |
| A03967 | 33806784 | Children (Basel) | MAFLD in Obese Children: A Challenging Definition. | 2021 | Details |
| A03970 | 33805912 | Int J Mol Sci | Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling. | 2021 | Details |
| A03983 | 33802047 | J Clin Med | Natural History of NAFLD. | 2021 | Details |
| A03991 | 33799865 | Nutrients | A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. | 2021 | Details |